Title:
STABLE ORAL FORMULATION CONTAINING BENZIMIDAZOLE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO2002032425
Kind Code:
A3
Abstract:
An enteric formulation containing at least one benzimidazole derivative, said formulation comprising: a core containing at least one benzimidazole derivative and at least one lipophilic antioxidant, and an enteric envelope protecting the core at least at a pH of 3 to 5, preferably at a pH pf 1 to 5.
Inventors:
VANDERBIST FRANCIS (BE)
SERENO ANTONIO (BE)
BAUDIER PHILIPPE (BE)
SERENO ANTONIO (BE)
BAUDIER PHILIPPE (BE)
Application Number:
PCT/BE2001/000184
Publication Date:
January 16, 2003
Filing Date:
October 18, 2001
Export Citation:
Assignee:
GALEPHAR M F (BE)
VANDERBIST FRANCIS (BE)
SERENO ANTONIO (BE)
BAUDIER PHILIPPE (BE)
VANDERBIST FRANCIS (BE)
SERENO ANTONIO (BE)
BAUDIER PHILIPPE (BE)
International Classes:
A61K9/20; A61K9/28; A61K31/355; A61K31/44; A61K31/4439; (IPC1-7): A61K31/4439; A61K31/44; A61K9/28; A61K9/20
Domestic Patent References:
| WO1999032091A1 | 1999-07-01 |
Foreign References:
| EP1004305A1 | 2000-05-31 | |||
| US5708017A | 1998-01-13 | |||
| DE19918434A1 | 2000-10-26 |
Download PDF:
Previous Patent: EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS
Next Patent: FURTHER IMPROVEMENTS IN AND RELATING TO THE CONTROL OF COCCIDIA
Next Patent: FURTHER IMPROVEMENTS IN AND RELATING TO THE CONTROL OF COCCIDIA